Additionally, individuals with CSF display endothelial dysfunction, as determined by biomarker assessment, namely endothelin-1 and nitric oxide concentrations or plasma levels of asymmetric dimethylarginine [8,9]. This evidence concerns the gene EDN1 and endothelial dysfunction.